vs
Side-by-side financial comparison of GE HealthCare (GEHC) and WESCO INTERNATIONAL INC (WCC). Click either name above to swap in a different company.
WESCO INTERNATIONAL INC is the larger business by last-quarter revenue ($6.1B vs $5.1B, roughly 1.2× GE HealthCare). GE HealthCare runs the higher net margin — 8.0% vs 2.6%, a 5.4% gap on every dollar of revenue. On growth, WESCO INTERNATIONAL INC posted the faster year-over-year revenue change (10.3% vs 7.4%). GE HealthCare produced more free cash flow last quarter ($112.0M vs $27.5M). Over the past eight quarters, WESCO INTERNATIONAL INC's revenue compounded faster (6.5% CAGR vs 3.0%).
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures...
Wesco International, Inc. is a publicly traded American holding company for Wesco Distribution, an electrical distribution and services company based in Pittsburgh, Pennsylvania.
GEHC vs WCC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.1B | $6.1B |
| Net Profit | $411.0M | $159.8M |
| Gross Margin | 38.5% | 21.2% |
| Operating Margin | 10.0% | 5.3% |
| Net Margin | 8.0% | 2.6% |
| Revenue YoY | 7.4% | 10.3% |
| Net Profit YoY | -30.1% | -3.4% |
| EPS (diluted) | $0.85 | $3.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $5.1B | — | ||
| Q4 25 | $5.7B | $6.1B | ||
| Q3 25 | $5.1B | $6.2B | ||
| Q2 25 | $5.0B | $5.9B | ||
| Q1 25 | $4.8B | $5.3B | ||
| Q4 24 | $5.3B | $5.5B | ||
| Q3 24 | $4.9B | $5.5B | ||
| Q2 24 | $4.8B | $5.5B |
| Q1 26 | $411.0M | — | ||
| Q4 25 | $588.0M | $159.8M | ||
| Q3 25 | $446.0M | $187.5M | ||
| Q2 25 | $486.0M | $174.5M | ||
| Q1 25 | $564.0M | $118.4M | ||
| Q4 24 | $721.0M | $165.4M | ||
| Q3 24 | $470.0M | $204.3M | ||
| Q2 24 | $428.0M | $232.1M |
| Q1 26 | 38.5% | — | ||
| Q4 25 | 39.7% | 21.2% | ||
| Q3 25 | 38.7% | 21.3% | ||
| Q2 25 | 39.6% | 21.1% | ||
| Q1 25 | 42.1% | 21.1% | ||
| Q4 24 | 42.8% | 21.2% | ||
| Q3 24 | 41.7% | 22.1% | ||
| Q2 24 | 41.4% | 21.9% |
| Q1 26 | 10.0% | — | ||
| Q4 25 | 14.5% | 5.3% | ||
| Q3 25 | 12.7% | 5.6% | ||
| Q2 25 | 13.1% | 5.5% | ||
| Q1 25 | 13.2% | 4.5% | ||
| Q4 24 | 15.1% | 5.5% | ||
| Q3 24 | 13.9% | 6.1% | ||
| Q2 24 | 12.6% | 5.9% |
| Q1 26 | 8.0% | — | ||
| Q4 25 | 10.3% | 2.6% | ||
| Q3 25 | 8.7% | 3.0% | ||
| Q2 25 | 9.7% | 3.0% | ||
| Q1 25 | 11.8% | 2.2% | ||
| Q4 24 | 13.6% | 3.0% | ||
| Q3 24 | 9.7% | 3.7% | ||
| Q2 24 | 8.8% | 4.2% |
| Q1 26 | $0.85 | — | ||
| Q4 25 | $1.28 | $3.33 | ||
| Q3 25 | $0.98 | $3.79 | ||
| Q2 25 | $1.06 | $3.83 | ||
| Q1 25 | $1.23 | $2.10 | ||
| Q4 24 | $1.58 | $3.01 | ||
| Q3 24 | $1.02 | $3.81 | ||
| Q2 24 | $0.93 | $4.28 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | $10.1B | — |
| Stockholders' EquityBook value | $10.7B | $5.0B |
| Total Assets | $37.1B | $16.5B |
| Debt / EquityLower = less leverage | 0.95× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $4.5B | — | ||
| Q3 25 | $4.0B | — | ||
| Q2 25 | $3.7B | — | ||
| Q1 25 | $2.5B | — | ||
| Q4 24 | $2.9B | — | ||
| Q3 24 | $3.5B | — | ||
| Q2 24 | $2.0B | — |
| Q1 26 | $10.1B | — | ||
| Q4 25 | $10.0B | — | ||
| Q3 25 | $10.3B | — | ||
| Q2 25 | $10.3B | — | ||
| Q1 25 | $8.8B | — | ||
| Q4 24 | $9.0B | — | ||
| Q3 24 | $10.3B | — | ||
| Q2 24 | $9.2B | — |
| Q1 26 | $10.7B | — | ||
| Q4 25 | $10.4B | $5.0B | ||
| Q3 25 | $10.0B | $4.8B | ||
| Q2 25 | $9.7B | $4.8B | ||
| Q1 25 | $9.2B | $5.0B | ||
| Q4 24 | $8.4B | $5.0B | ||
| Q3 24 | $8.3B | $5.0B | ||
| Q2 24 | $7.8B | $4.9B |
| Q1 26 | $37.1B | — | ||
| Q4 25 | $36.9B | $16.5B | ||
| Q3 25 | $36.1B | $16.6B | ||
| Q2 25 | $35.5B | $16.2B | ||
| Q1 25 | $33.6B | $15.5B | ||
| Q4 24 | $33.1B | $15.1B | ||
| Q3 24 | $33.9B | $15.3B | ||
| Q2 24 | $31.9B | $15.1B |
| Q1 26 | 0.95× | — | ||
| Q4 25 | 0.96× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 1.06× | — | ||
| Q1 25 | 0.95× | — | ||
| Q4 24 | 1.06× | — | ||
| Q3 24 | 1.24× | — | ||
| Q2 24 | 1.18× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $71.9M |
| Free Cash FlowOCF − Capex | $112.0M | $27.5M |
| FCF MarginFCF / Revenue | 2.2% | 0.5% |
| Capex IntensityCapex / Revenue | — | 0.7% |
| Cash ConversionOCF / Net Profit | — | 0.45× |
| TTM Free Cash FlowTrailing 4 quarters | — | $25.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $71.9M | ||
| Q3 25 | — | $-82.7M | ||
| Q2 25 | $94.0M | $107.8M | ||
| Q1 25 | $250.0M | $28.0M | ||
| Q4 24 | — | $276.6M | ||
| Q3 24 | — | $302.1M | ||
| Q2 24 | $-119.0M | $-223.8M |
| Q1 26 | $112.0M | — | ||
| Q4 25 | — | $27.5M | ||
| Q3 25 | — | $-95.9M | ||
| Q2 25 | $8.0M | $86.0M | ||
| Q1 25 | $98.0M | $7.6M | ||
| Q4 24 | — | $252.3M | ||
| Q3 24 | — | $272.9M | ||
| Q2 24 | $-183.0M | $-244.6M |
| Q1 26 | 2.2% | — | ||
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | -1.5% | ||
| Q2 25 | 0.2% | 1.5% | ||
| Q1 25 | 2.1% | 0.1% | ||
| Q4 24 | — | 4.6% | ||
| Q3 24 | — | 5.0% | ||
| Q2 24 | -3.8% | -4.5% |
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | 0.7% | ||
| Q3 25 | 2.1% | 0.2% | ||
| Q2 25 | 1.7% | 0.4% | ||
| Q1 25 | 3.2% | 0.4% | ||
| Q4 24 | 1.9% | 0.4% | ||
| Q3 24 | 1.9% | 0.5% | ||
| Q2 24 | 1.3% | 0.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.45× | ||
| Q3 25 | — | -0.44× | ||
| Q2 25 | 0.19× | 0.62× | ||
| Q1 25 | 0.44× | 0.24× | ||
| Q4 24 | — | 1.67× | ||
| Q3 24 | — | 1.48× | ||
| Q2 24 | -0.28× | -0.96× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GEHC
| Imaging revenues | $2.3B | 45% |
| AVS revenues | $1.3B | 26% |
| PDx revenues | $770.0M | 15% |
| PCS revenues | $704.0M | 14% |
| Other revenues | $18.0M | 0% |
WCC
| CSS | $2.4B | 40% |
| EES | $2.3B | 37% |
| UBS | $1.4B | 23% |
